Carlyle Credit Income Fund Business Update
Carlyle Credit Income Fund reported its unaudited net asset value (NAV) per common share as of August 31, 2026. The company disclosed that its management's estimated NAV per share was $3.23.
ALFA USA Filings
Every alert, straight from SEC EDGAR
Every business update filing by a US-listed company that our alert engine sent, newest first.
Alerts
Time
685 alerts with these filters
Carlyle Credit Income Fund reported its unaudited net asset value (NAV) per common share as of August 31, 2026. The company disclosed that its management's estimated NAV per share was $3.23.
Rithm Perpetual Life Residential Trust reported its Net Asset Value (NAV) per share as of August 31, 2026, for its Class J and Class E common shares. The total NAV was approximately $161 million, with Class J shares valued at $20.1448 and Class E shares at $20.3053. The trust's portfolio primarily consists of residential transition and mortgage loans valued at approximately $672.7 million, offset by $523.5 million in secured financings.
NexPoint Capital, Inc. filed an 8-K under Item 8.01 (Other Events). For Business Development Companies (BDCs) and non-traded funds, this item is typically used to provide routine operational updates such as Net Asset Value (NAV) per share or portfolio composition updates.
Orion Energy Systems announced a follow-on commitment from a major US retail customer for an LED lighting and IoT retrofit project estimated at $10M to $15M. Due to this additional workflow, the company increased its FY 2027 revenue guidance to a range of $100M to $102M.
“Orion has once again earned a significant increase in its scope of work on behalf of one of the biggest names in retailing. Orion continues to add substantially to its workflow with this Global Fortune 50 company, as we expand our management of LED Lighting, IoT, Maintenance and Electrical Contracting.”
Sally Washlow, Orion Chief Executive Officer
Coya Therapeutics announced it has enrolled the 100th patient in its Phase 2/3 ALSTARS trial evaluating COYA 302 for the treatment of ALS. The company expects to complete full enrollment of 120 participants shortly and remains on track to report topline data in early Q2 2027.
Zeo ScientifiX announced plans to expand its commercial and provider-support operations into Georgia and Tennessee. The move follows the enactment of new state laws in both jurisdictions that establish frameworks for stem cell and regenerative medicine therapies. The expansion aims to support healthcare providers with biologics, education, and implementation support as they navigate these evolving state-level regulatory environments.
American Express disclosed monthly delinquency and write-off statistics for its U.S. Consumer and U.S. Small Business card portfolios for the period ending August 31, 2026. As of August 31, total card balances held for investment reached $160.3 billion, with net write-off rates of 1.7% for U.S. Consumer and 2.2% for U.S. Small Business. These periodic metrics provide investors with insight into the credit quality and performance of the company's core lending portfolios.
Rocket Pharmaceuticals announced alignment with the FDA on the pivotal Phase 2 trial design for RP-A501 in Danon disease, including a 12-patient pivotal population and 12-month co-primary endpoints. The FDA's review of initial safety data from the first three patients supports continued enrollment and dosing under a modified protocol, with completion of dosing expected by mid-2027.
Bread Financial provided a monthly performance update for August 2026, reporting a net principal loss rate of 6.40% and a delinquency rate of 5.36%. Both metrics showed improvement compared to August 2025, while average credit card and other loans grew 5.6% year-over-year to $18.6 billion.
Artificial Intelligence Technology Solutions (AITX) issued a statement calling for clearer regulatory guardrails and data privacy boundaries in the AI-powered security industry. The company highlighted its own approach to data privacy, noting that its Robotic Assistance Devices (RAD) subsidiary maintains data in customer-specific environments rather than pooled surveillance networks and does not utilize facial recognition.
Capital One Financial Corporation disclosed its monthly credit performance metrics for August 2026, reporting a 4.16% net charge-off rate and a 3.57% delinquency rate for its domestic credit card portfolio. The company's auto loan segment showed a 1.66% net charge-off rate and a 4.54% delinquency rate for the same period. These periodic operational updates provide investors with insight into the credit quality and performance of the company's loan portfolios between quarterly earnings reports.
Eagle Point Credit Company provided an unaudited estimate of its net asset value (NAV) per common share as of August 31, 2026. The company estimated the NAV to be between $4.29 and $4.39 per share.
Eagle Point Income Company provided an unaudited estimate of its net asset value (NAV) per common share as of August 31, 2026. The company expects the NAV to be in the range of $12.38 to $12.48 per share.
60 Degrees Pharmaceuticals submitted a Statement of Interest to the FDA requesting a Commissioner’s National Priority Voucher (CNPV) for its ARAKODA (tafenoquine) efficacy supplement for babesiosis. The company aims to submit a supplemental New Drug Application (sNDA) in early 2027, potentially making it the first FDA-approved treatment for the tick-borne disease. An interim analysis of its randomized controlled trial is scheduled for October 1, 2026.
QVC Group, Inc. filed its monthly operating report with the U.S. Bankruptcy Court for the Southern District of Texas for the period ending July 31, 2026. The report discloses a cash balance of $200.6 million and a net loss for the month, as the company continues its Chapter 11 reorganization process. Although the company's plan of reorganization was confirmed in July and became effective in August, these monthly reports are required for the duration of the bankruptcy proceedings.
The Federal Home Loan Bank of New York (FHLBNY) released its August 2026 President's Report, highlighting the announcement of $70.9 million in grants for its 2026 Affordable Housing Program (AHP) Round. The funding will support 47 affordable housing initiatives, creating or preserving over 2,400 homes and driving approximately $850 million in total development activity.
Phio Pharmaceuticals has submitted a meeting request and comprehensive briefing package to the FDA to support the next stage of clinical development for its lead candidate, PH-762. The submission follows the completion of a Phase 1b trial and outlines a proposed Phase 2b neoadjuvant study in cutaneous squamous cell carcinoma.
Bitmine Immersion Technologies announced that its total crypto, cash, and marketable securities holdings have reached $15.8 billion, including 5.96 million ETH tokens. The company now owns approximately 4.9% of the total Ethereum supply and reported that 5.07 million of its ETH tokens are currently staked through its MAVAN validator network.
DeFi Development Corp. reported that its treasury holdings grew by 55,491 SOL to a total of 2,388,923 SOL and SOL equivalents as of September 11, 2026. The company also established a $300 million at-the-market (ATM) offering program for its Series C Perpetual Preferred Stock (CHAD) to fund future SOL purchases, though no shares have been sold yet. This update reflects the company's ongoing strategy to accumulate and compound Solana assets through its treasury infrastructure.
Strive, Inc. provided an operational update disclosing the purchase of 469 bitcoin between September 8 and September 11, 2026, at an average price of $77,954 per coin. The company reported its total bitcoin holdings reached 25,000 as of September 11, 2026, alongside updates to its cash position and share count metrics.
Soluna Holdings announced that ERCOT has conditionally classified its 100 MW Project Dorothy campus as 'Base Load' in Batch Zero, preserving its interconnection capacity. This follows a similar classification for the company's 166 MW Project Kati, bringing its total conditionally classified base load capacity in Texas to 266 MW. The company has also submitted a request for an additional 50 MW at the Dorothy site which is currently under study.
VisionWave Holdings has been prequalified by the Liberia Petroleum Regulatory Authority (LPRA) to enter into direct negotiations for a Production Sharing Contract (PSC) in Liberia. The invitation follows a due diligence review but does not yet grant any rights to specific petroleum blocks or hydrocarbon resources. There is no assurance that negotiations will result in a definitive agreement or that the company will secure the necessary capital for future operations.
Immunocore has achieved its target enrollment of 540 patients in the Phase 3 TEBE-AM clinical trial evaluating tebentafusp (KIMMTRAK) for the treatment of advanced melanoma. The trial is a registrational study, and the company expects to report topline overall survival data as early as the end of 2026.
Synchrony Financial disclosed its monthly credit performance statistics for the thirteen months ended August 31, 2026, reporting a 30+ day delinquency rate of 4.2% and an adjusted net charge-off rate of 4.9%. Period-end loan receivables stood at $103.0 billion, reflecting a slight increase from the prior month. These periodic updates provide investors with visibility into the credit quality and loss trends of the company's consumer loan portfolio.
Intelligent Bio Solutions Inc. provided an update on its total shares outstanding, which reached 3,316,803 shares as of September 10, 2026. The increase resulted from the exercise of pre-funded warrants for 285,000 shares and the issuance of 4,333 restricted shares under an existing advisory agreement.